About the Study

Chronic Kidney Disease (CKD) and Iron Deficiency Anemia: A study on ferumoxytol treatment for CKD and iron deficiency

Iron deficiency anemia (IDA) is common in adults and children who have chronic kidney disease (CKD). Iron therapy is the usual treatment for IDA. Iron therapy has been shown to restore iron levels and help the body normalize levels of hemoglobin (the part of your blood that carries oxygen). The purpose of this research study is to evaluate the experimental drug ferumoxytol when compared to iron sucrose in children with CKD and iron deficiency anemia or who are at risk of developing IDA. Another purpose of the study is to see what happens to ferumoxytol in children's bodies and how the body clears the drug from blood. This is called pharmacokinetics (PK). PK blood samples will be obtained from some ferumoxytol-treated subjects who agree to have these samples taken. The study doctor may ask subjects to participate in this part of the study or inform them that PK samples are not needed.

Interested in learning more?

Full Study Name: AMAG - Ferumoxytol drug for children with CKD and iron deficiency anemia